Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
Pyridone derivatives as potent and selective VLA-4 integrin antagonistsJason Witherington, Vincent Bordas, Alessandra Gaiba, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 2003
6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)Jason Witherington, Vincent Bordas, Alessandra Gaiba, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
5-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)Jason Witherington, Vincent Bordas, Stephen L Garland, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2003
5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)Jason Witherington, Vincent Bordas, David Haigh, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 2003
6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)Jason Witherington, Vincent Bordas, Alessandra Gaiba, et al.Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonistsJason Witherington, Emma L Blaney, Vincent Bordas, et al.Chemmedchem|August 11, 2022
The First Class of Small Molecules Potently Disrupting the YAP-TEAD Interaction by Direct CompetitionPascal Furet, Vincent Bordas, Mickaël Le Douget, et al.Journal of Medicinal Chemistry|September 23, 2011
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinaseVito Guagnano, Pascal Furet, Carsten Spanka, et al.Bioorganic & Medicinal Chemistry Letters|October 19, 2007
Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identificationTom D Heightman, Jackie S Scott, Mark Longley, et al.Journal of Medicinal Chemistry|March 4, 2026
Discovery of Clinical Candidate IAG933, a Potent YAP-TEAD PPI DisrupterMarkus Vögtle, Holger Sellner, Emilie Chapeau, et al.Pageof 2